Skip to main content
main-content

Zeitschrift

Clinical and Translational Oncology

Clinical and Translational Oncology 6/2020

Ausgabe 6/2020

Inhaltsverzeichnis ( 24 Artikel )

12.08.2019 | Editorial | Ausgabe 6/2020

SEOR recommendations on the use of protons

M. Lloret-Saez-Bravo, J. Giralt-L de Sagredo, J. Contreras-Martinez, C. Ferrer-Albiach

09.08.2019 | Editorial | Ausgabe 6/2020

A spotlight on cancer researchers in Spain: new paradigms and disruptive ideas

S. Ramón y Cajal, P. Sancho, L. Soucek, H. Peinado, M. Abad, M. Valiente, A. Efeyan, J. Pardo, V. Quesada, J. Jimeno, P. M. Duque, A. Antón, I. Varela, A. J. Schuhmacher

21.08.2019 | Editorial | Ausgabe 6/2020

Ethical commitment of Spanish oncologists to patients with prostate cancer: reflections on the statements of the new ASTRO/AUA guideline (2019 guideline amendment)

F. Casas, G. Oses, K. S. Cortes, T. D. Barreto, D. Muñoz

27.09.2019 | Review Article | Ausgabe 6/2020

The utilization of saliva as an early diagnostic tool for oral cancer: microRNA as a biomarker

J. S. Ghizoni, R. Nichele, M. T. de Oliveira, S. Pamato, J. R. Pereira

05.10.2019 | Review Article | Ausgabe 6/2020

Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer

G. Wang, Y. He, Y. Sun, W. Wang, X. Qian, X. Yu, Y. Pan

26.09.2019 | Special Article | Ausgabe 6/2020 Open Access

Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo, R. Álvarez-Alegret

13.08.2019 | Research Article | Ausgabe 6/2020

Prognostic role of interleukin-6 in renal cell carcinoma: a meta-analysis

Y. Wang, Y. Zhang

07.08.2019 | Research Article | Ausgabe 6/2020

Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes

A. Cortellini, A. Leonetti, A. Catino, P. Pizzutillo, B. Ricciuti, A. De Giglio, R. Chiari, P. Bordi, D. Santini, R. Giusti, M. De Tursi, D. Brocco, F. Zoratto, F. Rastelli, F. Citarella, M. Russano, M. Filetti, P. Marchetti, R. Berardi, M. Torniai, D. Cortinovis, E. Sala, C. Maggioni, A. Follador, M. Macerelli, O. Nigro, A. Tuzi, D. Iacono, M. R. Migliorino, G. Banna, G. Porzio, K. Cannita, M. G. Ferrara, E. Bria, D. Galetta, C. Ficorella, M. Tiseo

07.08.2019 | Research Article | Ausgabe 6/2020

Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy

P. Cascales Campos, L. A. Martinez Insfran, D. Wallace, J. Gil, E. Gil, A. Gonzalez Gil, J. Martínez, J. L. Alonso Romero, R. Gonzalez Sanchez, P. Parrilla

07.08.2019 | Research Article | Ausgabe 6/2020

Important prognostic factors in leiomyosarcoma survival: a National Cancer Database (NCDB) analysis

J. Gootee, N. Sioda, S. Aurit, C. Curtin, P. Silberstein

31.08.2019 | Research Article | Ausgabe 6/2020 Open Access

Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer

C. C. Kirwan, T. Descamps, J. Castle

19.08.2019 | Research Article | Ausgabe 6/2020

Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol

S. Salah, F. Abuhijla, T. Ismail, S. Yaser, I. Sultan, H. Halalsheh, A. Shehadeh, S. Abdelal, A. Almousa, O. Jaber, R. Abu-Hijlih

21.09.2019 | Research Article | Ausgabe 6/2020

TLI in pediatric patients

A. Ocanto, A. Escribano, L. Glaría, I. Rodríguez, C. Ferrer, C. Huertas, A. Pérez, R. Morera

19.09.2019 | Research Article | Ausgabe 6/2020

Efficacy of osimertinib for the treatment of previously EGFR TKI treated NSCLC patients: a meta-analysis

Z.-X. Li, W. Zhao, Q. Sun, M.-S. Tang, Q.-J. Xia, M.-S. Dong

25.09.2019 | Research Article | Ausgabe 6/2020

Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma

F. Consoli, M. Bersanelli, G. Perego, S. Grisanti, B. Merelli, A. Berruti, F. Petrelli

24.09.2019 | Research Article | Ausgabe 6/2020

Detection of novel mitochondrial mutations in cytochrome C oxidase subunit 1 (COX1) in patients with familial adenomatous polyposis (FAP)

E. Afkhami, M. M. Heidari, M. Khatami, F. Ghadamyari, S. Dianatpour

01.10.2019 | Research Article | Ausgabe 6/2020

Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies

T. Sakakida, T. Ishikawa, Y. Chihara, S. Harita, J. Uchino, Y. Tabuchi, S. Komori, J. Asai, T. Narukawa, A. Arai, H. Tsunezuka, T. Kosuga, H. Konishi, M. Moriguchi, H. Yasuda, F. Hongo, M. Inoue, S. Hirano, O. Ukimura, Y. Itoh, T. Taguchi, K. Takayama

30.09.2019 | Research Article | Ausgabe 6/2020

Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab

R. Liu, X. Zhao, W. Guo, M. Huang, L. Qiu, W. Zhang, Z. Zhang, W. Li, X. Zhu, Z. Chen

26.09.2019 | Research Article | Ausgabe 6/2020

Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer

V. Valentí, J. Ramos, C. Pérez, L. Capdevila, I. Ruiz, L. Tikhomirova, M. Sánchez, I. Juez, M. Llobera, E. Sopena, J. Rubió, R. Salazar

04.10.2019 | Research Article | Ausgabe 6/2020

Detection of incident breast and colorectal cancer cases from an administrative healthcare database in Catalonia, Spain

J. M. Escribà, M. Banqué, F. Macià, J. Gálvez, L. Esteban, L. Pareja, R. Clèries, X. Sanz, X. Castells, J. M. Borrás, J. Ribes

21.08.2019 | Correspondence | Ausgabe 6/2020

Standardized versus research-based PAM50 intrinsic subtyping of breast cancer

A. Prat, J. S. Parker

30.09.2019 | Correspondence | Ausgabe 6/2020

Comment on “Prognostic factors and survival in Ewing’s sarcoma treated by limb salvage surgery”

J. Weng, M. Xie, Z. Xu, Z. Wang

21.09.2019 | Correspondence | Ausgabe 6/2020

Treatment of radiation-induced myelopathy with bevacizumab

G. Cañedo, I. Solis, C. González-San Segundo, L. Madero, A. Lassaletta

06.02.2020 | Correction | Ausgabe 6/2020 Open Access

Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo, R. Álvarez-Alegret

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise